I
Injective
Fintech · New York City, United States · Founded 2018
Investors
28 investors on Injective's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Injective has talent and traffic
across markets
Talent graph
The shape of Injective's talent
Dealroom maps Injective's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Capital deployed
Injective's 4 investments and acquisitions.
Every disclosed deal where Injective appeared as a backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Injective's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Injective's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Injective
An AI-synthesized read of the highest-engagement posts about Injective on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Injective on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.